0

FDA Warns to Discontinue Use Zicam

Explaining the Cases

Zicam is a popular non-prescription zinc nasal spray. Its manufacturer markets it as a medication to shorten the duration of the common cold. Zicam has been associated with the onset of a condition known as anosmia, which leaves the user with a potentially permanent loss of smell and taste. These side effects typically are irreversible. The federal Food and Drug Administration (FDA) currently is collecting and evaluating reports of severe reactions to Zicam.

Zicam Manufacturer Describes Reports of Anosmia as “Completely Unfounded”

Although there are widespread reports of potential problems with the medication, the manufacturer of Zicam refuses to warn users about the possible dangers of the drug. Matrixx Initiatives, the manufacturer of Zicam, reported on their web site that the medication is “safe” even though there is an admission that they had not conducted any studies on the loss of smell.

The manufacturer of Zicam went even further when it released a notice on February 6, 2004 “reaffirming” the safety of Zicam. The manufacturer claimed:

Reports alleging anosmia—or loss of smell—in a small number of patients using zinc gluconate intranasal gels for the treatment of the common cold are completely unfounded and misleading.

These safety notices issued by Matrixx were made even though the company admitted it had not conducted any studies on loss of smell and in the face of numerous user reports and news stories linking the nasal spray with anosmia.

More recently, on June 16, 2009, the FDA advised consumers to discontinue use of several Zicam Cold Remedy products due to the risk of anosmia, a potentially permanent loss of smell. Matrixx Initiatives, the manufacturer of Zicam, settled approximately 340 cases in January 2006 involving people who alleged anosmia following use of Zicam. The FDA indicated it had received complaints from 130 consumers dating back to 1999.

The FDA issued a warning letter stating the products no longer can be marketed without FDA approval. Matrixx Initiatives previously took the position that Zicam was a homeopathic drug not subject to FDA regulation.

If you have been injured by taking Zicam, please contact Ed Wallis at (901) 527-2125, send him an EMAIL by clicking HERE, or fill out this FORM:

Your Name (required)

Your Email (required)

Subject

Your Message

FREE CASE EVALUATION
Do not delay, call us today.


CALL 901.527.2125
OR FILL OUT THIS FORM:

Name:

Phone:

E-mail:

About Your Claim:



Please read our DISCLAIMER


CLICK THE REPORT ABOVE FOR A FREE REPORT: TEN THINGS EVERY PERSON WITH AN ADVANCED BIONICS COCHLEAR IMPLANT FAILURE SHOULD KNOW




CLICK EACH AREA FOR MORE INFORMATION.

Medical Malpractice

Laser Eye Surgery and LASIK Malpractice

Nursing Home Injuries

Tennessee Mesothelioma Lawyer

Tennessee Asbestos Lawyer

Cochlear Implant Litigation

Student Sexual Assault

Car Accident

Jones Act and Maritime Law

Wellbutrin Heart Defect

Reglan - Tardive Dyskinesia

Accutane Injuries

Transvaginal Mesh Injuries

Medical Device Litigation

Pharmaceutical Drug and Medication Litigation



ADVANCED BIONICS COCHLEAR IMPLANT RECALL

If you were the recipient of an Advanced Bionics Model HiRes90k cochlear implant and have sustained physical or emotional injuries as a result of the recall of this medical device, please call Tim Edwards or Ed Wallis at (901) 527-2125 or send us an E-MAIL today. You can also visit the COCHLEAR IMPLANT LITIGATION PAGE for more information on the HiRes90k recall.



WELLBUTRIN MAY CAUSE BIRTH DEFECTS

A recent study published in the American Journal of Obstetrics and Gynecology suggests that women who take Wellbutrin during early pregnancy may run a greater risk for having a child born with a heart birth defect, including left outflow heart defects. If you took Bupropion hydrochloride, Wellbutrin®, Wellbutrin XL®, and Wellbutrin XR® and your child was born with a birth defect, please call Tim Edwards or Ed Wallis at (901) 527-2125 or send us an E-MAIL today. You can also visit the WELLBUTRIN HEART DEFECT INFORMATION PAGE for more information.